ATC code C01 Cardiac therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup C01 is part of the anatomical group C Cardiovascular system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC01.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
C01A Cardiac glycosides
edit- C01AA01 Acetyldigitoxin
- C01AA02 Acetyldigoxin
- C01AA03 Digitalis leaves
- C01AA04 Digitoxin
- C01AA05 Digoxin
- C01AA06 Lanatoside C
- C01AA07 Deslanoside
- C01AA08 Metildigoxin
- C01AA09 Gitoformate
- C01AA52 Acetyldigoxin, combinations
- C01AB01 Proscillaridin
- C01AB51 Proscillaridin, combinations
C01AC Strophanthus glycosides
edit- C01AC01 G-strophanthin
- C01AC03 Cymarin
C01AX Other cardiac glycosides
edit- C01AX02 Peruvoside
C01B Antiarrhythmics, class I and III
editC01BA Antiarrhythmics, class Ia
edit- C01BA01 Quinidine
- C01BA02 Procainamide
- C01BA03 Disopyramide
- C01BA04 Sparteine
- C01BA05 Ajmaline
- C01BA08 Prajmaline
- C01BA12 Lorajmine
- C01BA13 Hydroquinidine
- C01BA51 Quinidine, combinations excluding psycholeptics
- C01BA71 Quinidine, combinations with psycholeptics
C01BB Antiarrhythmics, class Ib
edit- C01BB01 Lidocaine
- C01BB02 Mexiletine
- C01BB03 Tocainide
- C01BB04 Aprindine
C01BC Antiarrhythmics, class Ic
edit- C01BC03 Propafenone
- C01BC04 Flecainide
- C01BC07 Lorcainide
- C01BC08 Encainide
- C01BC09 Ethacizine
C01BD Antiarrhythmics, class III
edit- C01BD01 Amiodarone
- C01BD02 Bretylium tosilate
- C01BD03 Bunaftine
- C01BD04 Dofetilide
- C01BD05 Ibutilide
- C01BD06 Tedisamil
- C01BD07 Dronedarone
C01BG Other antiarrhythmics, class I and III
edit- C01BG01 Moracizine
- C01BG07 Cibenzoline
- C01BG11 Vernakalant
C01C Cardiac stimulants excluding cardiac glycosides
editC01CA Adrenergic and dopaminergic agents
edit- C01CA01 Etilefrine
- C01CA02 Isoprenaline
- C01CA03 Norepinephrine
- C01CA04 Dopamine
- C01CA05 Norfenefrine
- C01CA06 Phenylephrine
- C01CA07 Dobutamine
- C01CA08 Oxedrine
- C01CA09 Metaraminol
- C01CA10 Methoxamine
- C01CA11 Mephentermine
- C01CA12 Dimetofrine
- C01CA13 Prenalterol
- C01CA14 Dopexamine
- C01CA15 Gepefrine
- C01CA16 Ibopamine
- C01CA17 Midodrine
- C01CA18 Octopamine
- C01CA19 Fenoldopam
- C01CA21 Cafedrine
- C01CA22 Arbutamine
- C01CA23 Theodrenaline
- C01CA24 Epinephrine
- C01CA25 Amezinium metilsulfate
- C01CA26 Ephedrine
- C01CA27 Droxidopa
- C01CA28 Centhaquine
- C01CA30 Combinations
- C01CA51 Etilefrine, combinations
- C01CE01 Amrinone
- C01CE02 Milrinone
- C01CE03 Enoximone
- C01CE04 Bucladesine
- QC01CE90 Pimobendane
C01CX Other cardiac stimulants
edit- C01CX06 Angiotensinamide
- C01CX07 Xamoterol
- C01CX08 Levosimendan
- C01CX09 Angiotensin II
- C01CX10 Omecamtiv mecarbil
C01D Vasodilators used in cardiac diseases
edit- C01DA02 Glyceryl trinitrate
- C01DA04 Methylpropylpropanediol dinitrate
- C01DA05 Pentaerithrityl tetranitrate
- C01DA07 Propatylnitrate
- C01DA08 Isosorbide dinitrate
- C01DA09 Trolnitrate
- C01DA13 Eritrityl tetranitrate
- C01DA14 Isosorbide mononitrate
- C01DA20 Organic nitrates in combination
- C01DA38 Tenitramine
- C01DA52 Glyceryl trinitrate, combinations
- C01DA54 Methylpropylpropanediol dinitrate, combinations
- C01DA55 Pentaerithrityl tetranitrate, combinations
- C01DA57 Propatylnitrate, combinations
- C01DA58 Isosorbide dinitrate, combinations
- C01DA59 Trolnitrate, combinations
- C01DA63 Eritrityl tetranitrate, combinations
- C01DA70 Organic nitrates in combination with psycholeptics
- C01DB01 Flosequinan
C01DX Other vasodilators used in cardiac diseases
edit- C01DX01 Itramin tosilate
- C01DX02 Prenylamine
- C01DX03 Oxyfedrine
- C01DX04 Benziodarone
- C01DX05 Carbocromen
- C01DX06 Hexobendine
- C01DX07 Etafenone
- C01DX08 Heptaminol
- C01DX09 Imolamine
- C01DX10 Dilazep
- C01DX11 Trapidil
- C01DX12 Molsidomine
- C01DX13 Efloxate
- C01DX14 Cinepazet
- C01DX15 Cloridarol
- C01DX16 Nicorandil
- C01DX18 Linsidomine
- C01DX19 Nesiritide
- C01DX21 Serelaxin
- C01DX22 Vericiguat
- C01DX51 Itramin tosilate, combinations
- C01DX52 Prenylamine, combinations
- C01DX53 Oxyfedrine, combinations
- C01DX54 Benziodarone, combinations
C01E Other cardiac preparations
editC01EA Prostaglandins
edit- C01EA01 Alprostadil
C01EB Other cardiac preparations
edit- C01EB02 Camphor
- C01EB03 Indometacin
- C01EB04 Crataegus glycosides
- C01EB05 Creatinolfosfate
- C01EB06 Fosfocreatine
- C01EB07 Fructose 1,6-diphosphate
- C01EB09 Ubidecarenone
- C01EB10 Adenosine
- C01EB11 Tiracizine
- C01EB13 Acadesine
- C01EB15 Trimetazidine
- C01EB16 Ibuprofen
- C01EB17 Ivabradine
- C01EB18 Ranolazine
- C01EB21 Regadenoson
- C01EB22 Meldonium
- C01EB23 Tiazotic acid
- C01EB24 Mavacamten
- QC01EB90 Sirolimus
C01EX Other cardiac combination products
editSee also
edit- Class II antiarrhythmics (beta blocking agents) are in the ATC group C07.
- Class IV antiarrhythmics (cardiac calcium channel blockers) are in the ATC group C08D.
References
edit- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code C01". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QC01". WHO Collaborating Centre for Drug Statistics Methodology.